Back to Portfolio
Visit Website
Optomed
MedTechHandheld AI-powered fundus cameras enabling accessible global eye screening.
Ophthalmic ImagingAI DiagnosticsMedical DevicesFDA-Cleared
Invested
2025
Founded
2004
Headquarters
Oulu, Finland
Sector
MedTech
About
Optomed is a leading global provider of handheld fundus cameras and AI-powered screening software, listed on Nasdaq Helsinki and with products sold in over 60 countries. Their Aurora AEYE is the first FDA-cleared handheld AI fundus camera for autonomous diabetic retinopathy screening. With over 50 international patents and CE, FDA, and CFDA approvals, Optomed partners with major eye care companies to transform diagnostic eye care worldwide.